Biotech Law 
PROLOR Biotech Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa – Genetic Engineering News
PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company … except as required under applicable law.
PROLOR Biotech, Inc. : PROLOR Biotech Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa – 4-traders (press release)
The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. 07:35a PROLOR Biotech …
Have biopesticides come of age?
Travis Glare, John Caradus, Wendy Gelernter, Trevor Jackson, Nemat Keyhani, Jürgen Köhl, Pamela Marrone, Louise Morin, Alison Stewart. Biopesticides based on living microbes and their bioactive compounds have been researched and promoted as replacements for synthetic pesticides for many years. … Continue reading
Administration’s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth – StreetInsider.com
will discourage biotech innovation. The 12-year term of data protection for biologics included in the Affordable Care Act received widespread bipartisan support in the Congress during the consideration of the biosimilar pathway and is now settled U.S. law.
Administration’s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Fo – FierceBiotech
WASHINGTON–(BUSINESS WIRE)– Biotechnology Industry Organization (BIO … during the consideration of the biosimilar pathway and is now settled U.S. law. The 12-year period continues to maintain strong bipartisan support in the Congress.
Administration’s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth – Business Wire
will discourage biotech innovation. The 12-year term of data protection for biologics included in the Affordable Care Act received widespread bipartisan support in the Congress during the consideration of the biosimilar pathway and is now settled U.S. law.
Sirona Biochem Announces Results in Key Study for Biological Inducer – Phramalive.com
competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.
PROLOR Biotech Announces Positive Preclinical Results from Comparative Study of its Long-Acting Clotting Factor VIIa – Yahoo Finance
PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company … except as required under applicable law.
College of Law hosts ‘Who owns your body?’ – The Daily Athenaeum
The lecture, concerning law and medical research … Moore was unaware his doctor had made a partnership with a biotech company to develop a patent on his cell line, Goodwin said. “When Moore sues, he has 13 causes of action, … Continue reading
Organic farmers’ suit against Monsanto’s genetically modified seeds – 89.3 KPCC
Biotechnology and agricultural giant Monsanto sells most … the Organic Seed Growers and Trade Association (OSGATA) filed a law suit in 2011 challenging Monsanto’s right to patent seeds. OGSATA also believes that pollen from Monsanto …
